Qpex Biopharma nabs $33 mln Series A
Qpex Biopharma, a developer of antiobiotics, has raised $33 million in Series A financing. New Enterprise Associates led the round with participation from Adams Street Partners, LYZZ Capital, Hatteras Venture Partners and Stanford University Draper Fund.
22 October 2018•1 min read
